NewEdge Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

NewEdge Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$290	–	4071
2024 Q3	$290	Buy	+500	New	+$280	﹤0.01%	3657
2024 Q2	–	Sell	-2,750	Closed	-$7.07K	–	4037
2024 Q1	$7.07K	Hold	2,750	–	–	﹤0.01%	3020
2023 Q4	$5.61K	Buy	2,750 +1,000	+57%	+$1.82K	﹤0.01%	3093
2023 Q3	$3.01K	Hold	1,750	–	–	﹤0.01%	2952
2023 Q2	$3.41K	Hold	1,750	–	–	﹤0.01%	2937
2023 Q1	$4.87K	Hold	1,750	–	–	﹤0.01%	2782
2022 Q4	$6	Buy	+1,750	New	+$5K	﹤0.01%	3789

Other funds holding GRTS

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

NewEdge Advisors's GRTS Position: Q4 2024 in Review

NewEdge Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 500 shares — an estimated $290 sold.

NewEdge Advisors first reported a position in GRTS in Q4 2022 and held it in 7 quarters. The position peaked at $7.07K in Q1 2024. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

NewEdge Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
NewEdge Advisors sold 500 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $290.
NewEdge Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2022 and held it in 7 quarters.
NewEdge Advisors's Gritstone bio, Inc. Common Stock position peaked at $7.07K in Q1 2024.
6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on NewEdge Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.